Biomechanical Properties of the Human Ascending Aortic Wall in Aneurysm
Biomechanical and Elastic Properties of the Ascending Wall of the Human Aorta in Aneurysm
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of the study is to analyze the efficacy of the surgical tretment in patients with ascending aortic aneurysm and dilatation. And to assess rate of negative clinical scenarios in non-oparated patients with ascending aortic dilatation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2022
CompletedFirst Submitted
Initial submission to the registry
April 21, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedOctober 23, 2023
October 1, 2023
Same day
April 21, 2023
October 18, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
mortality
assess early and late death cases in aneurysm and dilatation groups in operated and nonoperarted patients
up to 5 years
aortic growth
assess of the aortic growth in mm during foloow up in nonoperated patients
up to 5 years
Study Arms (2)
Surgery
ACTIVE COMPARATORPatients with ascending aortic aneurysm and dlatation who undergo surgical tretment
Non-surgery
NO INTERVENTIONPatients with ascending aortic dlatation who undergo surveillance
Interventions
Replacement of the ascending aorta in case of anerysm and dilatation
Eligibility Criteria
You may qualify if:
- Ascending aortic aneurysm (50 mm and more)
- Ascending aortic dilatation (45-49 mm)
You may not qualify if:
- Aortic dissection
- Patients with known/documented coagulopathy
- Oncological disease (high degrees)
- Severe chronic heart failure
- Refusal of surgical treatment
- Patients in renal failure or currently being treated with renal replacement therapy (RRT) or estimated glomerular filtration rate (eGFR) \< 30 ml/min/1.73m2
- Severe carotid disease, defined as: any patient with previously documented carotid stenosis of \> 70%, without neurological deficits; or carotid stenosis \> 50% with neurological deficits; or previous carotid endarterectomy or stenting
- Pre-existing severe neurological impairment or inability to accurately assess neurocognitive function as determined by the operating surgeon
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tomsk NRMC
Tomsk, 634012, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dmitry S Panfilov, PhD, MD
Cardiology Research Institute, Tomsk National Research Medic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2023
First Posted
May 3, 2023
Study Start
March 21, 2022
Primary Completion
March 21, 2022
Study Completion
August 1, 2023
Last Updated
October 23, 2023
Record last verified: 2023-10